Skip to content

A prospective multicenter cohort study of early methylprednisolone treatment in acute stroke

A prospective multicenter cohort study of early methylprednisolone treatment in acute stroke

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051664
Enrollment
Unknown
Registered
2021-09-30
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute stroke

Interventions

Standard treatment group:standard therapy
methylprednisolone group:standard therapy and methylprednisolone

Sponsors

The Second Affiliated Hospital of the Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age >=18 years old; 2. The time from onset to randomization is within 24 hours; 3. Preliminary judgment as anterior circulation ischemic stroke based on clinical symptoms or imaging examination; 4. Computed tomography angiography (CTA)/magnetic resonance angiography (MRA)/digital subtraction angiography (DSA) confirmed the occlusion of the intracranial segment of the internal carotid artery and the of the middle cerebral artery, basilar artery, and decided to undergo endovascular treatment; 5. The patient or family members signed the written informed consent.

Exclusion criteria

Exclusion criteria: No.

Design outcomes

Secondary

MeasureTime frame
Improvement in 90-day MRS scores;Death at 90 days;mRS score;

Primary

MeasureTime frame
90-day mRS Score;

Countries

China

Contacts

Public ContactZi Wenjie, Yang Qingwu

The Second Affiliated Hospital of the Army Medical University

yangqwmlys@163.com+86 18523033816, +86 13657638868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026